They have an exorbitant spend and no indication that this drug even works. A very tricky clinical development path.
Two lies in one post! Impressive. There is strong evidence that EDP-235 robustly inhibits Covid and the amount of money needed to get it through phase 2 trials isn't very high.
I notice your alias was just made today and that was nonsensical post is your only post. Short alert, short alert.